SCHEMBL7880985

SCHEMBL7880985

CN(C)Cc1cccc(COc2cccc3cc(C(=O)N(C)C(=N)N)[nH]c23)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGMT P16455 1/20 0.42
IDO1 P14902 1/20 0.38
TP53 P04637 3/20 0.37
MAPT P10636 3/20 0.37
MRGPRX4 Q96LA9 2/20 0.36
LMNA P02545 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
FLT3 P36888 1/20 0.36
PARP1 P09874 1/20 0.36
F2 P00734 1/20 0.35
NOS1 P29475 2/20 0.35
NOS2 P35228 1/20 0.35
MAOB P27338 1/20 0.35
CFD P00746 1/20 0.34
PLG P00747 1/20 0.34
PLAU P00749 1/20 0.34
F11 P03951 1/20 0.34
KLKB1 P03952 1/20 0.34
F7 P08709 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873765 0.93 MAPT (0.37) MGMTIDO1TP53MAPTLMNA
SCHEMBL7882405 0.92 GYS1 (0.39) IDO1TP53MAPTMRGPRX4LMNA
SCHEMBL7877636 0.91 CFD (0.43) MGMTIDO1TP53MAPTMRGPRX4
Hydrochloric Acid SCHEMBL7877859 0.89 SRD5A2 (0.42) IDO1TP53MAPTMRGPRX4LMNA
SCHEMBL7873718 0.87 CFD (0.38) IDO1TP53MAPTMRGPRX4HRH4
SCHEMBL7879978 0.87 FLT3 (0.35) IDO1TP53MAPTLMNAHRH4
SCHEMBL7877457 0.86 MEN1 (0.39) IDO1TP53MAPTLMNAHRH4
SCHEMBL7873462 0.86 F10 (0.42) IDO1TP53MAPTLMNAHRH4
SCHEMBL7884412 0.86 MGMT (0.38) MGMTMAPTMRGPRX4MAOB
SCHEMBL7881382 0.85 AR (0.40) IDO1TP53MAPTLMNAHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed